icon-folder.gif   Conference Reports for NATAP  
 
  EACS - European AIDS Conference
Oct 12-15 2011
Belgrade, Serbia
Back grey_arrow_rt.gif
 
 
 
Switching from Efavirenz/Emtricitabine/Tenofovir DisoproxilFumarate(EFV/FTC/TDF) Single Tablet Regimen (STR) to Emtricitabine/Rilpivirine/Tenofovir DisoproxilFumarate(FTC/RPV/TDF) STR in VirologicallySuppressed, HIV-1 Infected Subjects
 
 
  Reported by Jules Levin EACS Belgrade Oct 12-15 2011
 
C Cohen,1A Mills,2E DeJesus,3B Rashbaum,4
C Brinson,5K Yale,6S Ramanathan,6H Wang,6
A Jandourek,6and A Cheng6
1Community Research Initiative, Boston, MA ; 2Anthony Mills MD Inc, Los Angeles, CA; 3Orlando Immunology Ctr, Orlando, FL; 4Capital Medical Associates, Washington, DC; 5Central Texas Clinical Research, Austin, TX; 6Gilead Sciencesnc., Foster City, CA

EACS1.gif

EACS2.gif

EACS3.gif

EACS4.gif

EACS5.gif

EACS6.gif

EACS7.gif

EACS8.gif

EACS9.gif

EACS10.gif